Patents by Inventor Jay Shukla

Jay Shukla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957658
    Abstract: Compositions of a stabilized chlorthalidone suspension and methods for making a stabilized chlorthalidone suspension include chlorthalidone along with a solubilizing and/or wetting agent, a suspending agent, and a viscosity increasing agent and/or an anti-caking agent, wherein the stabilized chlorthalidone suspension is a uniform dispersion with consistent concentration of chlorthalidone throughout the composition and storage.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: April 16, 2024
    Assignee: Nivagen Pharmaceuticals, Inc.
    Inventors: Govind R. Jagadale, Dasaradhi Lakkaraju, Bala Tripura Sundari Chodavarapu, Niravkumar Prajapati, Anand Shukla, Jay Shukla
  • Publication number: 20240075674
    Abstract: A nozzle for forming a container preform into a plastic container includes a first cylindrical portion having a first diameter and including a first seal, a second cylindrical portion having a second diameter less than the first diameter and including a second seal, and a transition portion between the first and second cylindrical portions.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 7, 2024
    Inventors: Jay Clarke Hanan, Abhishek Shukla
  • Patent number: 11878076
    Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.
    Type: Grant
    Filed: January 24, 2023
    Date of Patent: January 23, 2024
    Assignee: NIVAGEN PHARMACEUTICALS, INC.
    Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
  • Patent number: 11672823
    Abstract: Described is an aqueous calcium gluconate solution formulated without calcium saccharate, which can be stored in a flexible plastic bag and can be terminally sterilized.
    Type: Grant
    Filed: July 22, 2022
    Date of Patent: June 13, 2023
    Assignee: Nivagen Pharmaceuticals, Inc.
    Inventors: Thirupathi Mangali, Bala Tripura Sundari Chodavarapu, Anand Shukla, Jay Shukla, Dasaradhi Lakkaraju
  • Publication number: 20230157959
    Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.
    Type: Application
    Filed: January 24, 2023
    Publication date: May 25, 2023
    Applicant: Nivagen Pharmaceuticals, Inc.
    Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
  • Publication number: 20230043597
    Abstract: Described is an aqueous calcium gluconate solution formulated without calcium saccharate, which can be stored in a flexible plastic bag and can be terminally sterilized.
    Type: Application
    Filed: July 22, 2022
    Publication date: February 9, 2023
    Applicant: Nivagen Pharmaceuticals, Inc.
    Inventors: Thirupathi Mangali, Bala Tripura Sundari Chodavarapu, Anand Shukla, Jay Shukla, Dasaradhi Lakkaraju
  • Publication number: 20220354794
    Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenyl ethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.
    Type: Application
    Filed: June 30, 2022
    Publication date: November 10, 2022
    Applicant: Nivagen Pharmaceuticals, Inc.
    Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
  • Patent number: 11406598
    Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: August 9, 2022
    Assignee: NIVAGEN PHARMACEUTICALS, INC.
    Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju
  • Publication number: 20210369673
    Abstract: Compositions of a stabilized chlorthalidone suspension and methods for making a stabilized chlorthalidone suspension include chlorthalidone along with a solubilizing and/or wetting agent, a suspending agent, and a viscosity increasing agent and/or an anti-caking agent, wherein the stabilized chlorthalidone suspension is a uniform dispersion with consistent concentration of chlorthalidone throughout the composition and storage.
    Type: Application
    Filed: May 26, 2021
    Publication date: December 2, 2021
    Applicant: Nivagen Pharmaceuticals, Inc.
    Inventors: Govind R. Jagadale, Dasaradhi Lakkaraju, Bala Tripura Sundari Chodavarapu, Niravkumar Prajapati, Anand Shukla, Jay Shukla
  • Publication number: 20210085608
    Abstract: A composition of, method for producing, and use of an amorphous lyophilized Phenobarbital Sodium having high purity are presented. The amorphous lyophilized Phenobarbital Sodium is storage-stable being essentially void of impurities (e.g., phenylethylacetylurea (PEAU), 2-ethyl-2-phenylmalonamide (2EPMM), and/or alpha-phenylbutyrylguanidine (PBG)) upon reconstitution in water.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 25, 2021
    Applicant: Nivagen Pharmaceuticals, Inc.
    Inventors: Bala Tripura Sundari Chodavarapu, Thirupathi Mangali, Jay Shukla, Anand Shukla, Dasaradhi Lakkaraju